Assessment of High Risk Pregnant Women by Fetal Echocardiography

Munaf Jarallah Yaseen; Elaf Khashea Neamaa; Ghazi Farhan Haji

doi:10.54133/ajms.v7i2.1476

Authors

Munaf Jarallah Yaseen Department of Pediatrics, College of Medicine, University of Baghdad, Baghdad, Iraq
Elaf Khashea Neamaa Department of Echocardiography, Baghdad Teaching Hospital, Medical city Complex, Baghdad, Iraq https://orcid.org/0009-0005-8299-2430
Ghazi Farhan Haji Department of Medicine, College of Medicine, University of Baghdad University, Baghdad, Iraq https://orcid.org/0009-0000-5480-2445

DOI:

https://doi.org/10.54133/ajms.v7i2.1476

Keywords:

Congenital heart diseases, High risk pregnancies, Fetal echo, Prenatal diagnosis

Abstract

Background: Congenital heart defects (CHDs) are the most prevalent type of congenital defect. Early identification of CHDS increases postnatal treatment options and outcomes. Objective: To compare the rate of CHDS in the general pregnant population to those at high risk. It also assesses the efficacy of using periodic fetal echocardiography throughout pregnancy to test for CHDs. Methods: A prospective cross-sectional study was undertaken at the Medical City complex between September 1st, 2023, and May 1st, 2024. The fetal heart was screened antenatally during the mid-trimester. Data were gathered from 250 pregnant women, with half of them classified as high-risk due to fetal or maternal risk factors associated with congenital heart abnormalities. These parameters were compared to those seen in low-risk pregnancies to establish the need for fetal echocardiography. Results: The study comprised 250 pregnant women, with 125 in each of the low-risk and high-risk categories. The prenatal incidence of fetal cardiac disease was discovered to be 18%. Pregnancies with ultrasonography abnormalities had the highest prevalence, accounting for 37% of the overall high-risk category. In addition, 34 instances (14%) featured babies with minor cardiac abnormalities, while 6 cases (2%) involved fetuses with complicated cardiac disorders. Conclusions: The study found that CHDS is more common in high-risk pregnancies than in low-risk ones. All pregnant women, regardless of additional maternal concerns, should undergo prenatal screening, including CHDS detection.

Downloads

Download data is not yet available.

References

Sharma S, Kaur N, Kaur K, Pawar NC. Role of echocardiography in prenatal screening of congenital heart diseases and its correlation with postnatal outcome. J Clin Diagn Res. 2017;11(4):TC12-TC14. doi: 10.7860/JCDR/2017/25929.9750. DOI: https://doi.org/10.7860/JCDR/2017/25929.9750

Moon-Grady AJ, Donofrio MT, Gelehrter S, Hornberger L, Kreeger J, Lee W, et al. Guidelines and recommendations for performance of the fetal echocardiogram: An update from the American Society of Echocardiography. J Am Soc Echocardiogr. 2023;36(7):679-723. doi: 10.1016/j.echo.2023.04.014. DOI: https://doi.org/10.1016/j.echo.2023.04.014

Mohammed NB, Chinnaiya A. Evolution of foetal echocardiography as a screening tool for prenatal diagnosis of congenital heart disease. J Pak Med Assoc. 2011;61(9):904-909. PMID: 22360034.

Keighley CL, Skrzypek HJ, Wilson A, Bonning MA, Gilbert GL. Infections in pregnancy. Med J Aust. 2019;211(3):134-141. doi: 10.5694/mja2.50261. DOI: https://doi.org/10.5694/mja2.50261

Van Mieghem T, Hindryckx A, Van Calsteren K. Early fetal anatomy screening: who, what, when and why? Curr Opin Obstet Gynecol. 2015;27(2):143-150. doi: 10.1097/GCO.0000000000000161. DOI: https://doi.org/10.1097/GCO.0000000000000161

van Velzen CL, Clur SA, Rijlaarsdam ME, Bax CJ, Pajkrt E, Heymans MW, Bekker MN, Hruda J, de Groot CJ, Blom NA, Haak MC. Prenatal detection of congenital heart disease--results of a national screening programme. BJOG. 2016;123(3):400-407. doi: 10.1111/1471-0528.13274. DOI: https://doi.org/10.1111/1471-0528.13274

Hernandez-Andrade E, Patwardhan M, Cruz-Lemini M, Luewan S. Early evaluation of the fetal heart. Fetal Diagn Ther. 2017;42(3):161-173. doi: 10.1159/000477564. DOI: https://doi.org/10.1159/000477564

McAuliffe FM, Trines J, Nield LE, Chitayat D, Jaeggi E, Hornberger LK. Early fetal echocardiography--a reliable prenatal diagnosis tool. Am J Obstet Gynecol. 2005;193(3 Pt 2):1253-1259. doi: 10.1016/j.ajog.2005.05.086. DOI: https://doi.org/10.1016/j.ajog.2005.05.086

Sotiriadis A, Papatheodorou S, Eleftheriades M, Makrydimas G. Nuchal translucency and major congenital heart defects in fetuses with normal karyotype: a meta-analysis. Ultrasound Obstet Gynecol. 2013;42(4):383-389. doi: 10.1002/uog.12488. DOI: https://doi.org/10.1002/uog.12488

Machin GA. Differential diagnosis of hydrops fetalis. Am J Med Genet. 1981;9(4):341-350. doi: 10.1002/ajmg.1320090410. DOI: https://doi.org/10.1002/ajmg.1320090410

Society for Maternal-Fetal Medicine (SMFM); Norton ME, Chauhan SP, Dashe JS. Society for maternal-fetal medicine (SMFM) clinical guideline #7: nonimmune hydrops fetalis. Am J Obstet Gynecol. 2015;212(2):127-139. doi: 10.1016/j.ajog.2014.12.018. DOI: https://doi.org/10.1016/j.ajog.2014.12.018

Nicolaides KH, Azar G, Byrne D, Mansur C, Marks K. Fetal nuchal translucency: ultrasound screening for chromosomal defects in first trimester of pregnancy. BMJ. 1992;304(6831):867-869. doi: 10.1136/bmj.304.6831.867. DOI: https://doi.org/10.1136/bmj.304.6831.867

Snijders RJ, Noble P, Sebire N, Souka A, Nicolaides KH. UK multicentre project on assessment of risk of trisomy 21 by maternal age and fetal nuchal translucency thickness at 10-14 weeks of gestation. Fetal Med Found First Trimester Screen Group. Lancet. 1998;352(9125):343-346. doi: 10.1016/s0140-6736(97)11280-6. DOI: https://doi.org/10.1016/S0140-6736(97)11280-6

Rosa RCM, Rosa RFM, Zen PRG, Paskulin GA. Congenital heart defects and extracardiac malformations. Rev Paul Pediatr. 2013;31(2):243–251. doi: 10.1590/s0103-05822013000200017. DOI: https://doi.org/10.1590/S0103-05822013000200017

Rychik J, Ayres N, Cuneo B, et al. American Society of Echocardiography guidelines and standards for performance of the fetal echocardiogram. J Am Soc Echocardiogr. 2004;17:803-10. DOI: https://doi.org/10.1016/j.echo.2004.04.011

Raheem SA, Haji GF. Foetal echocardiography: A novel method for detecting congenital heart disease. J Clin Diag Res. 2019;13.2:22-24.‏ doi: 10.7860/JCDR/2019/38300.12607. DOI: https://doi.org/10.7860/JCDR/2019/38300.12607

Midan MF, Alsheemy RI, Eid SM, Abdel Salam ME. Efficacy of fetal echocardiography in prenatal diagnosis of congenital heart diseases. Int J Reprod Contracept Obstet Gynecol. 2018;5(5):1553-1557. doi: 10.18203/2320-1770.ijrcog20161323. DOI: https://doi.org/10.18203/2320-1770.ijrcog20161323

Chitra N, Vijayalakshmi IB. Fetal echocardiography for early detection of congenital heart diseases. J Echocardiogr. 2017;15(1):13-17. doi: 10.1007/s12574-016-0308-2. DOI: https://doi.org/10.1007/s12574-016-0308-2

Li M, Wang W, Yang X, Yan Y, Wu Q. Evaluation of referral indications for fetal echocardiography in Beijing. J Ultrasound Med. 2008;27(9):1291-1296. doi: 10.7863/jum.2008.27.9.1291. DOI: https://doi.org/10.7863/jum.2008.27.9.1291

Vaidyanathan B, Kumar S, Sudhakar A, Kumar RK. Conotruncal anomalies in the fetus: Referral patterns and pregnancy outcomes in a dedicated fetal cardiology unit in South India. Ann Pediatr Cardiol. 2013;6(1):15-20. doi: 10.4103/0974-2069.107227. DOI: https://doi.org/10.4103/0974-2069.107227

Iftikhar M, Hyder SN, Aziz S. Frequency of congenital heart defects detected on fetal echocardiography in high-risk mothers. J Pioneer Med Sci. 2016;7(1):7-10.

Rocha LA, Araujo Júnior E, Rolo LC, Barros FS, Silva KP, Leslie AT, et al. Prenatal detection of congenital heart diseases: one-year survey performing a screening protocol in a single reference center in Brazil. Cardiol Res Pract. 2014;2014:175635. doi: 10.1155/2014/175635. DOI: https://doi.org/10.1155/2014/175635

Ozkutlu S, Akca T, Kafalı G, Beksac S. The results of fetal echocardiography in a tertiary center and comparison of low and high-risk pregnancies for fetal congenital heart defects. Anadolu Kardiyol Derg. 2010;10:263-269. doi: 10.5152/akd.2010.068. DOI: https://doi.org/10.5152/akd.2010.068

Clur SAB, Van Brussel PM, Mathijssen IB, Pajkrt E, Ottenkamp J, Bilardo CM. Audit of 10 years of referrals for fetal echocardiography. Prenat Diagn. 2011;31:1134-1140. doi: 10.1002/pd.2847. DOI: https://doi.org/10.1002/pd.2847

Yu Z, Xi Y, Ding W, Han S, Cao L, Zhu C, et al. Congenital heart disease in a Chinese hospital: pre- and postnatal detection, incidence, clinical characteristics and outcomes. Pediatr Int. 2011;53(6):1059-1065. doi: 10.1111/j.1442-200X.2011.03450.x. DOI: https://doi.org/10.1111/j.1442-200X.2011.03450.x

Galindo A, Herraiz I, Escribano D, Lora D, Melchor JC, de la Cruz J. Prenatal detection of congenital heart defects: a survey on clinical practice in Spain. Fetal Diagn Ther. 2011;29(4):287-295. doi: 10.1159/000322519. DOI: https://doi.org/10.1159/000322519

Dolk H, Loane M, Garne E. Congenital heart defects in Europe: prevalence and perinatal mortality, 2000 to 2005. Circulation. 2011;123(8):841-849. doi: 10.1161/CIRCULATIONAHA.110.958405. DOI: https://doi.org/10.1161/CIRCULATIONAHA.110.958405

Nayak K, Chandra GSN, Shetty R, Narayan PK. Evaluation of fetal echocardiography as a routine antenatal screening tool for detection of congenital heart disease. Cardiovasc Diagn Ther. 2016;6(1):44-49. doi: 10.3978/j.issn.2223-3652.2015.12.01.

Pham A, Melchior M. Screening for fetal congenital heart disease. CMAJ. 2017;189(12):E468. doi: 10.1503/cmaj.160700. DOI: https://doi.org/10.1503/cmaj.160700

Akram NN, Yaseen MJ, Nori W. Identifying clinical and biochemical predictors of seizures in children with acute bacterial meningitis: insights from a cross-sectional study. Al-Rafidain J Med Sci. 2024;7(1):127-132. doi: 10.54133/ajms.v7i1.1106. DOI: https://doi.org/10.54133/ajms.v7i1.1106

Crispín Milart PH, Prieto-Egido I, Díaz Molina CA, Martínez-Fernández A. Detection of high-risk pregnancies in low-resource settings: a case study in Guatemala. Reprod Health. 2019;16(1):80. doi: 10.1186/s12978-019-0748-z. DOI: https://doi.org/10.1186/s12978-019-0748-z

Nori W, Akram N, Al-Kinani M. Radiological modalities for the assessment of fetal growth restriction: a comprehensive review. Al-Kindy Coll Med J. 2024;20(1):4-13. doi: 10.47723/nz221421. DOI: https://doi.org/10.47723/nz221421